-
KCP-330-020
The purpose of this study is to see if the investigational drug, selinexor, has any effects in eligible participants with ...
-
UPCC 10519 / I5B-MC-Y001: An Open-Label Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma
The purpose of this program is to allow patients who, in consultation with their treating physician, feel it is in ...
-
PHASE I TRIAL OF AUTOLOGOUS T CELLS ENGINEERED TO EXPRESS NY-ESO-1 TCR AND GENE EDITED TO ELIMINATE ENDOGENOUS TCR AND ...
This is a Phase 1 first-in-human trial proposed to determine the safety profile and manufacturing feasibility of a single infusion ...
-
Integrated biomarker PET/CT imaging trial for assessing hypoxia in soft tissue sarcomas using a novel PET/CT tracer
This is a pilot study. Subjects with primary soft tissue sarcoma of the extremities may be eligible for this study ...
Showing - of trials